Treatments for early-stage Dupuytren’s disease: an evidence-based approach
Current treatments for Dupuytren’s disease are limited to late-stage disease when patients have developed flexion contractures and have impaired hand function. They all have limitations, including the risk of recurrence and complications. The use of treatments for early-stage disease, such as intral...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
SAGE Publications
2023
|